Tumor redifferentiation in papillary thyroid carcinoma after retinoic acid administration;Rediferenciación tumoral en carcinoma papilar de tiroides tras la administración de ácido retinoico

Revista Espanola de Medicina Nuclear

Volumn 23, Issue 3, 2004, Pages 193-196

  Camacho Marti V ^a   Estorch Cabrera, M ^a   Mena Gonzalez E ^a   Fuertes Manuel, J ^a   Hernandez Fructuoso M A ^a   Flotats Giralt, A ^a   Carrio Gasset I ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Differentiated thyroid cancer; Retinoic acid; Tumor redifferentiation

Indexed keywords

IODINE 131; ISOTRETINOIN; THYROXINE;

AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE THERAPY; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION;

EID: 7644219568     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13061695     Document Type: Article

References (14)

1. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M et al. Surgical reintervention for differentiated thyroid carcinoma. Br J Surg 1994;80:1131-4.
2. Ross SA, McCaffery PJ, Drager UC, de Luca LM. Retinoids in embryonal development. Physiol Rev 2000;80:1021-54.
3. Bravermann LE, Utiger RD, eds. The thyroid: a fundamental and clinical text. Philadelphia: Lippincott-Raven, 1996.
4. Schmutzler C, Koehrle J. Innovative strategies for the treatment of thyroid cancer. Eur J End 2000;143:15-24.
5. Freitas JE, Gross MD, Ripley S, Shapiro B. Radionuclide diagnosis and therapy of thyroid cancer: current status report. Semin Nucl Med 1985;15:106-31.
6. Brabant G, Maenhaut C, Köhrle J, Scheumann G, Dralle H, Hoang-Vu C et al. Human thyrotropin receptor gene: expression in thyroid tumours and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 1991;82:R7-R12.
7. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism Eur J Endocrinol 1999;141:443-57.
8. Ross SA, McCaffery PJ, Drager UC, De Luca LM. Retinoids in embryonal development. Physiol Rev 2000;80:1021-54.
9. Schmutzler C, Brtko J, Bienen K, Khorle J. Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom. Experimental and Clinical Endocrinology Diabetes 1996;104:16-9.
10. van Herle AJ, Agatep ML, Padua DN, Totanes TL, Canlapan DV, Van Herle HML et al. Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells in vitro. J End Metab 1990;71:755-63.
11. Chomienne C, Fenaux P, Degos L. Retinoid differentiation therapy in promyelocytic leukaemia. FASEB J 1996;10:1025-30.
12. Hansen LA, Sigman CC, Andreola F, Ross SA, Kellof GJ, de Luca LM. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000;21:1271-9.
13. Grünwald F, Menzel C, Bender H, Palmedo H, Otte R, Fimmers R et al. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med 1998;39:1903-6.
14. Simon D, Köber C, Krausch M, Segering J, Groth P, Görges R et al. Clinical impact of retinoids in redifferentiation therapy of avanced thyroid cancer: final results of a pilot study. Eur J Nucl Med 2002;29:775-82.